Toward safer sedation in patients with cirrhosis: have we done enough?

Gastrointestinal Endoscopy

Volumn 70, Issue 2, 2009, Pages 269-271

  Thuluvath, Paul J ^a,b  

^a MERCY MEDICAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; CYTOCHROME; CYTOCHROME P3A4; CYTOCHROME P450 3A4; DIAZEPAM; FENTANYL; MIDAZOLAM; NORPETHIDINE; OPIATE ANTAGONIST; PETHIDINE; PROPOFOL; PROTEIN; SEDATIVE AGENT; UNCLASSIFIED DRUG;

ALCOHOL ABUSE; ANALGESIA; ANESTHESIST; ANESTHETIC RECOVERY; CENTRAL NERVOUS SYSTEM FUNCTION; CLINICAL PRACTICE; COGNITION; CONSCIOUS SEDATION; COST EFFECTIVENESS ANALYSIS; CRITICAL FLICKER FUSION; DISEASE SEVERITY; DRUG ABUSE; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG HYDROLYSIS; DRUG METABOLISM; DRUG SAFETY; DRUG SENSITIVITY; EDITORIAL; EUROPE; GASTROINTESTINAL ENDOSCOPY; GENERAL ANESTHESIA; HEPATIC ENCEPHALOPATHY; HEPATITIS C; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; LIVER; LIVER BLOOD FLOW; LIVER CIRRHOSIS; LIVER DISEASE; LIVER METABOLISM; MEMORY; NONALCOHOLIC FATTY LIVER; NORTH AMERICA; ORIENTATION; PHYSICIAN; PORTOSYSTEMIC ANASTOMOSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PSYCHOMETRY; UNITED STATES; VISION;

CONSCIOUS SEDATION; ENDOSCOPY, GASTROINTESTINAL; HEPATIC ENCEPHALOPATHY; HUMANS; HYPNOTICS AND SEDATIVES; LIVER CIRRHOSIS; SAFETY;

EID: 67650964143     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2009.01.029     Document Type: Editorial

References (13)

1. Hamdy N.A., Kennedy H.J., Nicholl J., et al. Sedation for gastroscopy: a comparative study of midazolam and Diazemuls in patients with and without cirrhosis. Br J Clin Pharmacol 22 (1986) 643-647
2. Assy N., Rosser B.G., Grahame G.R., et al. Risk of sedation for upper GI endoscopy exacerbating subclinical hepatic encephalopathy in patients with cirrhosis. Gastrointest Endosc 49 (1999) 690-694
3. Vasudevan A.E., Goh K., and Bulgiba A.M. Impairment of psychomotor responses after conscious sedation in cirrhotic patients undergoing therapeutic upper GI endoscopy. Am J Gastroenterol 97 (2002) 1717-1721
4. Weston B.R., Chadalawada V., Chalasani N., et al. Nurse administered propofol versus midazolam and meperidine for upper endoscopy in cirrhotic patients. Am J Gastroenterol 98 (2003) 2440-2447
5. Bakti G., Fisch H.U., Karlaganis G., et al. Mechanism of excessive sedation response of cirrhotics to benzodiazepines: model experiment with triazolam. Hepatology 7 (1987) 629-638
6. Riphaus A., Gstettenbauer T., and Frenz M.B. Quality of psychomotor recovery after propofol sedation for routine endoscopy: a randomized and controlled study. Endoscopy 38 (2006) 677-683
7. McQuaid K.R., and Laine L. A systematic review and meta-analysis of randomized controlled trials of moderate sedation for endoscopic procedures for routine endoscopic procedures. Gastrointest Endosc 67 (2008) 910-923
8. Singh H., Poluha W., Cheung M., et al. Propofol for sedation during colonoscopy. Cochrane Database Syst Rev (2008) CD006268
9. Kanto J., and Gepts E. Pharmacokinetic implications for the clinical use of propofol. Clin Pharmacokinet 17 (1989) 308-326
10. Servis F., Cockshott I.D., Farinotti R., et al. Pharmacokinetics of propofol infusions in patients with cirrhosis. Br J Anaesth 65 (1990) 177-183
11. Amorós A., Aparicio J.R., Garmendia M., et al. Deep sedation with propofol does not precipitate hepatic encephalopathy during elective upper endoscopy. Gastrointest Endosc 70 (2009) 262-268
12. Kircheis G., Wettstein M., Timmermann L., et al. Critical flicker frequency for quantification of low grade hepatic encephalopathy. Hepatology 35 (2002) 357-366
13. Romero-Gomez M., Cordoba J., Jover R., et al. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology 45 (2007) 879-885